Pharma stocks tumble as US President Donald Trump signs executive order to encourage US drug manufacturing

All major pharma stocks tumbled on Tuesday, i.e. on May 6, 2025, as investors became apprehensive over President Donald Trump signing an executive order that aims to encourage US drug manufacturing. The executive order will focus on reducing the time it takes to approve pharmaceutical plants in the country. As a result, Nifty Pharma fell 1.66 per cent in the opening trade to open at 21,672.85 against the previous close of Rs 21,775.75. Shares of Lupin, Cipla, Natco Pharma, Aurobindo Pharma were down by around 2 per cent today.

Business